A Multi-Centric Study Assessing Safety and Efficacy of Everolimus in Adult Chinese Patients With Tuberous Sclerosis Complex Associated Renal Angiomyolipomas

BACKGROUND: Everolimus has been approved in China for adult patients with TSC-AML (tuberous sclerosis associated renal angiomyolipomas) not requiring immediate surgery and has been previously shown to be an effective treatment option for TSC-AML in the Chinese population METHODS: This is an open lab...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenda, Guo, Gang, Shi, Guohai, Wei, Xin, Hu, Zhiquan, Li, Hanzhong, Zhang, Xu, Ye, Dingwei, Zhang, Yushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290768/
https://www.ncbi.nlm.nih.gov/pubmed/35860575
http://dx.doi.org/10.3389/fonc.2022.871723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290768/
https://www.ncbi.nlm.nih.gov/pubmed/35860575
http://dx.doi.org/10.3389/fonc.2022.871723

Ejemplares similares